Pricing for Multi-Indication Drugs in the Italian Regulatory Context
{{output}}
Background: The authorization of new therapeutic indications for drugs already reimbursed by the Italian National Health Service (NHS) represents a matter of importance. This study aims to estimate the additional discount attribu... ...
